From an Eli Lilly campus where pharmaceuticals are made to a new medical school and innovation district, the Charlotte region ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

When President Donald Trump declared in May that he wanted drug companies to voluntarily cut their prices, few pharmaceutical ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...

Friday’s announcement is the latest in a series of events in which Trump has boasted of securing cooperation from drug makers ...

Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...

The Brown County Community Foundation is pleased to announce the recipient of the 2026 Lilly Endowment Community Scholarship ...

The President said more deals would be announced next week, and suggested White House pressure will also come to bear on health insurers soon.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.